Clinical Trials

301 enrolled

Phase 2/3 Not yet recruiting

Breast Diseases, Breast Neoplasms

NCT06268327 2024-02-20

Adding Adjuvant Cisplatin and Gemicitabine Versus Capecitabine in Triple-negative Breast Cancer Patients in Non pCR After Neoadjuvant Standard Chemotherapy

30 enrolled

Phase 2/3 Active not recruiting

Breast Neoplasms

NCT02641847 2024-01-25

TA(E)C-GP Versus A(E)C-T for the High Risk TNBC Patients and Validation of the mRNA-lncRNA Signature

503 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT05189535 2024-01-23

"Prevention of Paclitaxel-Induced Peripheral Neuropathy in Breast Cancer Patients"

66 enrolled

Breast Neoplasms, Peripheral Nervous System Diseases

NCT05523609 2023-12-01

Vitamin D and Calcium Supplementation in Breast Cancer

40 enrolled

Breast Neoplasms

NCT02068092 2023-10-10

Olive Oil for High Risk Breast Cancer Prevention in Women

51 enrolled 6 charts

Breast Neoplasms

NCT05727098 2023-06-08

Dexmedetomedine and Ketamine in Erector Spinae Block for Postoperative Analgesia Following Mastectomy.

75 enrolled

Breast Neoplasms

NCT03564171 2023-04-12

Prehabilitation for Women Undergoing Pre-operative Chemotherapy for Breast Cancer

63 enrolled

Breast Neoplasms

NCT05804916 2023-04-07

Optical Surface Monitoring Technology-Guided Large-Segment Radiotherapy for Breast Cancer

Phase 2/3 Recruiting

556 enrolled

Breast Neoplasms

NCT04924699 2023-03-17

A Study of MRG002 in the Treatment of Patients With HER2-positive Unresectable Locally Advanced or Metastatic Breast Cancer

350 enrolled

Breast Neoplasms

NCT03354611 2023-03-16

Contrast-Enhanced Cone Beam Breast CT for Diagnostic Breast Imaging

Phase 2/3 Terminated

21 enrolled

Breast Neoplasms

NCT04803539 2023-02-21

Artemis

Phase 2/3 Recruiting

260 enrolled

Breast Neoplasms

NCT03150576 2022-11-14

PARTNER

Phase 2/3 Recruiting

780 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT05103644 2022-11-02

Study of the Therapeutic Effect of Atorvastatin on the Clinical Outcomes in HER2 Negative Breast Cancer Patients"

60 enrolled

Breast Neoplasms

NCT05595109 2022-10-26

Role of Silymarin in Chemotherapy Toxicity and Cognition Improvement in Breast Cancer Patients

56 enrolled

Phase 2/3 Active not recruiting

Breast Neoplasms, Peripheral Nervous System Diseases, Cognitive Dysfunction, Cardiotoxicity

NCT01057069 2022-10-12

neo-TN

310 enrolled

Breast Neoplasms

NCT05518292 2022-09-28

Comparison of Analgesic Efficacy of Ultrasound Guided Rhomboid Intercostal Block Versus Serratus Anterior Plane Block for Mastectomy Surgery

60 enrolled

Breast Neoplasms

NCT00247975 2022-08-16

Ability of L-carnitine to Prevent Heart Damage in Breast Cancer Patients Receiving Anthracycline Chemotherapy

Phase 2/3 Terminated

36 enrolled

Breast Neoplasms, Heart Failure

NCT04429893 2022-08-02

Magnesium Sulphate to Bupivicaine in Serratus Anterior Plane Block in Modified Radical Mastectomy

80 enrolled

Breast Neoplasms

NCT05253066 2022-02-23

Chidamide Combined With Exemestane (+/- Goserelin) Versus Neoadjuvant Chemotherapy in Patients of Stage II-III HR-positive/HER2-negative Breast Cancer

130 enrolled

Breast Neoplasms

NCT04059809 2021-08-13

Photobiomodulation for Breast Cancer Radiodermatitis

48 enrolled

Breast Neoplasms, Radiation Injuries, Radiodermatitis

NCT03580395 2021-07-09

Apatinib in Neoadjuvant Therapy for Patients With Breast Cancer

200 enrolled

Breast Neoplasms

NCT00397761 2021-02-17

Capecitabine and Paclitaxel (Albumin-Stabilized Nanoparticle Formulation) in Treating Women Undergoing Surgery for Stage II or Stage III Breast Cancer

Phase 2/3 Withdrawn